Menu
Currency
GWAS Study

Genome-wide association study on meningioma risk in Japan: a multicenter prospective study.

Yamada S, Umehara T, Sonehara K et al.

39002029 PubMed ID
GWAS Study Type
51277 Participants
43 Views
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

YS
Yamada S
UT
Umehara T
SK
Sonehara K
KN
Kijima N
KS
Kawabata S
TK
Takano K
KT
Kidani T
HR
Hirayama R
AH
Arita H
OY
Okita Y
KM
Kinoshita M
KN
Kagawa N
FT
Fujinaka T
FT
Fujita T
WA
Wakayama A
MK
Matsuda K
OY
Okada Y
KH
Kishima H
Chapter II

Abstract

Summary of the research findings

Purpose: Although meningiomas are the most common primary intracranial tumors, their genetic etiologies have not been fully elucidated. To date, only two genome-wide association studies (GWASs) have focused on European ancestries, despite ethnic differences in the incidence of meningiomas. The aim of this study was to conduct the first GWAS of Japanese patients with meningiomas to identify the SNPs associated with meningioma susceptibility.

401 Japanese ancestry cases, 50,876 Japanese ancestry controls

Chapter III

Study Statistics

Key metrics and study information

51277
Total Participants
GWAS
Study Type
No
Replicated
East Asian
Ancestry
Japan
Recruitment Country
Chapter IV

AI-Generated Summary

AI-generated by DNAGENICS

Independent AI summary of health and genetic findings from the published study

Important: This summary is AI-generated by DNAGENICS for informational purposes only. It was not created by, affiliated with, or endorsed by the researchers behind the original publication, and is based solely on that published research. It may contain errors or omissions. DNAGENICS disclaims all liability for any inaccuracies or consequences arising from use of this information. Verify all information against the original publication. This is not professional scientific review or medical advice.

AI Summary In Progress

Our AI-generated summary of this publication is being prepared. Please check back soon.